Browsing "1. Journal Papers" by Author : 4622

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 16 of 16

This table browses all dspace content
Issue DateTitleJournal Title
2014Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer?GASTRIC CANCER
2019Clinical Implications of Microsatellite Instability in Early Gastric Cancer JOURNAL OF GASTRIC CANCER
2023Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells EXPERIMENTAL AND MOLECULAR MEDICINE
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy ONCOTARGET
2021Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring JOURNAL OF KOREAN MEDICAL SCIENCE
2016Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer SCIENTIFIC REPORTS
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2018Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis BMB REPORTS
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2021Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort StudyANNALS OF SURGICAL ONCOLOGY
2019Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled studyANNALS OF SURGERY
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2018Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysisLANCET ONCOLOGY
2021Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers SCIENTIFIC REPORTS
2020Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answersJOURNAL OF HEPATOLOGY
1

Browse

Links